§ Funding Round
Mirador Therapeutics raised $250M Series B venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Fidelity Management & Research Company | — | — |
| Organization | — | |
Logos Capital | — | — |
| Organization | — | |
Point72 | — | — |
TCGX | — | — |
T. Rowe Price Associates | — | — |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$650M
Top Valuation
-
Mirador Therapeutics raised $250M in a Series B round.
The round was announced on 01/12/26.
